Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Disease Psychosis”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Not applicableStudy completedNCT02453763
What this trial is testing

In Vivo Imaging of Therapeutic Electric Current Flow

Who this might be right for
Parkinson DiseaseEpilepsyAlzheimer's Disease+4 more
University of Florida 17
Not applicableEnrolling By InvitationNCT07234851
What this trial is testing

Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.

Who this might be right for
Schizophrenia DisorderFrontotemporal Dementia, Behavioral VariantMajor Depressive Disorder (MDD)+2 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 150
Large-scale testing (Phase 3)Looking for participantsNCT06585787
What this trial is testing

Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Who this might be right for
Alzheimer Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 406
Large-scale testing (Phase 3)Looking for participantsNCT06947941
What this trial is testing

Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

Who this might be right for
Alzheimer DiseasePsychosis
Bristol-Myers Squibb 325
Not applicableLooking for participantsNCT05245903
What this trial is testing

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Who this might be right for
Alzheimer DiseaseDementia AlzheimersDementia+7 more
Mclean Hospital 40
Early research (Phase 1)Active Not RecruitingNCT07292233
What this trial is testing

A Food Effect Study of LY03020 in Healthy Subjects

Who this might be right for
SchizophreniaAlzheimer's Disease Psychosis
Luye Pharma Group Ltd. 16
Testing effectiveness (Phase 2)Ended earlyNCT03044249
What this trial is testing

MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Who this might be right for
PsychosisDementiaAggression+2 more
Mediti Pharma Inc. 81
Large-scale testing (Phase 3)Ended earlyNCT00160147
What this trial is testing

Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

Who this might be right for
Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
Solvay Pharmaceuticals 60
Not applicableStudy completedNCT05478681
What this trial is testing

Home-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer's Disease and Related Dementias (ADRD)

Who this might be right for
Alzheimer Disease
The University of Texas Health Science Center, Houston 3
Not applicableUnknownNCT02681822
What this trial is testing

Multi-center Imaging Genetics Studies in China

Who this might be right for
Alzheimer DiseaseSchizophreniaMajor Depressive Disorders
Tianjin Medical University General Hospital 10,000
Not applicableUnknownNCT03807388
What this trial is testing

ReMindCare App for Patients From First Episode of Psychosis Unit.

Who this might be right for
PsychosisSchizophreniaPsychotic Disorders+4 more
Instituto de Investigacion Sanitaria INCLIVA 140
Early research (Phase 1)Study completedNCT02392468
What this trial is testing

Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers

Who this might be right for
SchizophreniaAlzheimer Disease
Boehringer Ingelheim 61
Large-scale testing (Phase 3)Ended earlyNCT00287742
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Janssen Pharmaceutical K.K. 33
Not applicableStudy completedNCT05309577
What this trial is testing

Self-Care for Dementia Caregivers

Who this might be right for
AgingMental DisorderEating, Healthy+6 more
University of Pittsburgh 21
Early research (Phase 1)Not Yet RecruitingNCT06980207
What this trial is testing

A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 40
Early research (Phase 1)Not Yet RecruitingNCT06644573
What this trial is testing

Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia

Who this might be right for
Chronic InsomniaSleep DeprivationREM Behavior Disorder+34 more
Nyree Penn 100
Post-approval studies (Phase 4)Study completedNCT00009217
What this trial is testing

Treatment of Behavioral Symptoms in Alzheimer's Disease

Who this might be right for
Alzheimer's DiseasePsychosisAgitation
New York State Psychiatric Institute 44
Not applicableUnknownNCT00627029
What this trial is testing

Evaluation of Programs of Coordinated Care and Disease Management

Who this might be right for
Congestive Heart FailureDiabetesCoronary Artery Disease+6 more
Mathematica Policy Research, Inc. 18,277
Large-scale testing (Phase 3)Looking for participantsNCT06159673
What this trial is testing

ACP-204 in Adults With Alzheimer's Disease Psychosis

Who this might be right for
Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc. 1,074
Early research (Phase 1)Ended earlyNCT01137799
What this trial is testing

The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients

Who this might be right for
SchizophreniaAlzheimer's DiseaseCognition Disorders
Janssen Pharmaceutica N.V., Belgium 47
Next Page